Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

View source ↗

Summary

An ongoing trial evaluating whether prophylactic dexamethasone before infliximab infusions improves outcomes or reduces reactions in moderate-to-severe inflamma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decadron (Dexamethasone)
  • Remicade (infliximab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Inflammatory Bowel Disease (IBD), CD - Crohn's Disease | Status: RECRUITING